Web Stats Provided By Google Analytics

Friday, January 26, 2018

CymaBay Therapeutics Inc (CBAY) Director Sells $480,354.84 in Stock

... company's stock valued at $5,712,000 after purchasing an additional 170,126 shares during the last quarter. Ardsley Advisory Partners increased its holdings in CymaBay Therapeutics by 66.2% in the 2nd quarter. Ardsley Advisory Partners now owns ...
https://www.americanbankingnews.com/2018/01/26/cymabay-therapeutics-inc-cbay-director-sells-480354-84-in-stock.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+AmericanBankingNews+%28American+Banking+News%29

No comments:

Post a Comment

Popular Ardsley Roundup Posts